Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/01/2003US20030082191 Treatment for central nervous system disorders
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082189 Humanized neutralizing antibodies against hemolytic uremic syndrome
05/01/2003US20030082187 Combined cancer treatment methods using antibodies to aminophospholipids
05/01/2003US20030082185 Compositions and methods for inhibition of hiv-1 infection
05/01/2003US20030082184 Uses of mammalian cytokine; related reagents
05/01/2003US20030082183 Methods and compositions for treatment of ocular neovascularization and neural injury
05/01/2003US20030082182 Antiinflammatory agents, inflammatory bowel disorders, antiulcer agents
05/01/2003US20030082181 Growth differentiation factor-8
05/01/2003US20030082178 Administering chimera protein
05/01/2003US20030082177 Angiopoietins and methods of use thereof
05/01/2003US20030082176 Therapy for metabolism disorders
05/01/2003US20030082175 April receptor (BCMA) and uses thereof
05/01/2003US20030082173 Screening drugs that block lymphocytes; genetic engineered rodent
05/01/2003US20030082172 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
05/01/2003US20030082171 Deafness therapy, prevention; mylein protein vaccine
05/01/2003US20030082170 Protein from brucella species
05/01/2003US20030082169 System and method for the pretreatment of the endplates of an intervertebral disc
05/01/2003US20030082168 Prevent carbohydrate absorption; moderate metabolism; mixture of wheat amylase, plant extracts, linoleic acid and green tea
05/01/2003US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions
05/01/2003US20030082162 Therapy for genetic disorders in humans, animals; polypeptide coding antitrypsin
05/01/2003US20030082160 Differentiation of whole bone marrow
05/01/2003US20030082159 Lentiviral vector-mediated gene transfer and uses thereof
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003US20030082149 Inhibition of a target messenger rna with a modified u1 small nuclear rna
05/01/2003US20030082148 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/01/2003US20030082142 Replication incompetent herpes viruses for use in gene therapy
05/01/2003US20030082141 COX-2 function and wound healing
05/01/2003US20030082140 Increasing the amount of the cell differentiation associated protein, MDA-7 and decreasing RAS gene activity by administering a viral vector comprising an MDA-7 gene and an antisense ras oligonucleotide; treating pancreatic cancer
05/01/2003US20030082138 Administering a therapeutically effective dose of interferon-beta by intramuscular injection, two times per week or three times per week
05/01/2003US20030082137 Interleukin-3 gene therapy for cancer
05/01/2003US20030082135 Pathway of RANTES-mediated chemokine synthesis in astrocytes and methods of use therefor
05/01/2003US20030082134 Preventing and treating cachexia caused by cancer, acquired immunodeficient syndrome (AIDS), cardiac diseases, infectious disease, shock, burn, endotoxinemia, organ inflammation, surgery, diabetes, collagen diseases, radiotherapy
05/01/2003US20030082110 Lytic protein or peptides in a natural or modified form coded for by a bacteriophage
05/01/2003US20030082107 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
05/01/2003US20030079747 Method of decreasing fasting sugars and weight gains in diabetic patients
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2498591A1 Immunotherapy for reversing immune suppression
05/01/2003CA2478681A1 Telomerase interference
05/01/2003CA2471532A1 A synthetic chimeric fusion protein with immuno-therapeutic uses
05/01/2003CA2466732A1 Telomerase interference
05/01/2003CA2464795A1 Thymosin augmentation of genetic immunization
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464609A1 Use of egf to inhibit pathogenic infections of the urogenital tract
05/01/2003CA2464606A1 Method of modulating the immunoactivity of an immunocompetent graft by progenipoietin
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464368A1 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
05/01/2003CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464277A1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2464093A1 Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same
05/01/2003CA2464085A1 A combination product comprising melagatran and dexamethasone
05/01/2003CA2463960A1 Transient immortalization
05/01/2003CA2463803A1 Biphasic mixtures of glp-1 and insulin
05/01/2003CA2463772A1 Thrombin-cleavable chimeric proteins
05/01/2003CA2462163A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2461661A1 Use of histamine to treat liver disease
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2460665A1 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications
05/01/2003CA2458958A1 Method and apparatus for dispensing inhalator medicament
05/01/2003CA2458542A1 Enzyme inhibitors for inactivating allergens
05/01/2003CA2458070A1 Method for re-sensitizing vancomycin resistant bacteria using agents which selectively cleave a cell wall depsipeptide
04/2003
04/30/2003CN1415013A BASB059 polypeptides from neisseria meningitidis
04/30/2003CN1414976A Chimeric peptides used as immunogen and its antibody, and method for their use for immunization
04/30/2003CN1414972A Method for reducing immunogenicity of heterologous proteins by elimination of T-cell epitopes
04/30/2003CN1414971A Depsipeptide and congeners thereof for use as immunosuppressants
04/30/2003CN1414970A Transgenically produced fusion proteins
04/30/2003CN1414954A Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
04/30/2003CN1414871A Placental human necerokinin B precursor
04/30/2003CN1414865A 癌症的治疗 Treatment of cancer
04/30/2003CN1414860A Treatment of infertility
04/30/2003CN1414834A Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein
04/30/2003CN1414103A Human serine/threonine protein kitase, its coding sequence, preparation method and use
04/30/2003CN1414101A Desmocyte growth factor 11
04/30/2003CN1414100A Desmocyte growth factor 13
04/30/2003CN1414096A Preparation method of beta cyclodextrin carthworm plasmin modification enzyme
04/30/2003CN1414094A Using yeast secretion to express ruitipu enzyme
04/30/2003CN1414016A Leptospira adventitial protein, its code sequence and use
04/30/2003CN1414015A Leptospira adventitial protein, its code sequence and use
04/30/2003CN1414014A Leptospira adventitial protein its code sequence and use
04/30/2003CN1107072C Programing cell death induced molecule II
04/30/2003CN1106846C Antitumor agent
04/30/2003CN1106842C Usage of glutathione accelerator in preparating medicine for treating macular degeneration
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/29/2003US6555693 Compounds that affect the expression of genes essential for the proliferation of the pathogen; promoters or gene expression inhibition; binding to double-stranded DNA; fungicides; bactericides; viricides
04/29/2003US6555692 Polylactams having imidazole or pyrrole rings specifically bind with subnanomolar affinity to a predetermined DNA sequence; use in molecular biology and diagnostic medicine; gene expression control; target the minor groove of B-form
04/29/2003US6555672 Growth differentiation factor promoter and uses therefor
04/29/2003US6555670 Specifically expressed in haploid cells of the testis, located on the X-chromosome of a mammal; given nucleotide sequence; homologous to the drosophila gcl gene
04/29/2003US6555669 Nucleotide sequences coding preferential oligopeptide for use in human therapeutics and diagnostics; for use in the treatment of cancer and Parkinson's Disease
04/29/2003US6555667 Hypoxia-regulated genes
04/29/2003US6555666 Transcripts encoding immunomodulatory polypeptides
04/29/2003US6555660 A polypeptide having an amino acid sequence that differs from the preferred granulocyate colony stimulating factor sequence in no more than 15 amino acid residues, and a nonpeptide polymer attached to the amino acid of above polypeptide
04/29/2003US6555658 A novel human cytokine which can induce production of gamma-interferon in vitro in human peripheral blood lymphocytes; use treating cancer, infections such as AIDS (acquired immune deficiency syndrome)
04/29/2003US6555657 Isolated transcription factor for an alpha-amylase promoter in filamentous fungi
04/29/2003US6555656 Covalent modification of abnormal prion protein
04/29/2003US6555654 Low-density lipoprotein (LDL)-receptor related protein-3 (LRP-3); encoding nucleic acid; the gene is associated with type 1 diabetes (insulin dependent diabetes mellitus (IDDM); indications are it is the IDDM susceptibility gene IDDM4
04/29/2003US6555652 Tumor antigen peptide derivatives
1 ... 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 ... 3163